Stereotactic Surgical Devices Surge In Demand Amidst Rising Parkinson's Disease And Epilepsy Cases: Transformative Forces Shaping the Stereotactic Surgery Devices Market Landscape in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Stereotactic Surgery Devices Industry Market Size Be by 2025?
In recent times, the market size for stereotactic surgery devices has seen a consistent growth. The market, valued at $21.8 billion in 2024, is predicted to rise to $22.44 billion in 2025, reflecting a compound annual growth rate (CAGR) of 2.9%. The expansion during the historic period is a result of a move towards less invasive procedures, the inclusion of robotics and automation, growing need for precision and accuracy, and improved safety profiles.

What's the Long-Term Growth Forecast for the Stereotactic Surgery Devices Market Size Through 2029?
In the forthcoming years, the market for stereotactic surgery devices is predicted to witness robust expansion. By 2029, it is projected to reach $28.84 billion, growing at a compound annual growth rate (CAGR) of 6.5%. Factors fueling this growth during the forecast period encompass an increase in cancer incidences, the incorporation of artificial intelligence and machine learning, introducing the devices to new medical fields, a surge in the elderly population, along with customization and personalization in therapeutic procedures. Notable trends projected during this period entail enhancements in precision and accuracy, miniaturization of the devices, transition towards robotics and automation, individualized treatment methodologies, and a broader scope of applications and procedures.

View the full report here:
https://www.thebusinessresearchcompany.com/report/stereotactic-surgery-devices-global-market-report

What Are the Key Growth Drivers Fueling the Stereotactic Surgery Devices Market Expansion?
As the prevalence of Parkinson's disease and epilepsy rises, a subsequent expansion of the stereotactic surgical device market is anticipated. Parkinson's disease, a neurodegenerative condition, leads to involuntary tremors, slow movement, and rigid muscles. On the other hand, epilepsy is a neurological condition characterized by an increased likelihood of reoccurring, spontaneous seizures. These medical conditions can be treated using stereotactic surgical devices, popularly used in the management of movement disorders, epilepsy, pain, psychiatry, and specifically, Parkinson's disease. For instance, a study conducted by the Parkinson's Foundation, a national nonprofit organization based in New York, demonstrates that by 2022, the annual diagnoses of Parkinson's disease in the United States are predicted to exceed 90,000, a 50% increase from the earlier expected figure of 60,000 diagnoses per year. Currently, Parkinson's disease affects nearly a million people in the USA and this number is predicted to swell to 1.2 million by 2030. As such, it is evident that the growing incidences of Parkinson's disease and epilepsy are key contributors to the progress of the stereotactic surgical device market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10495&type=smp

What Are the Key Trends Driving Stereotactic Surgery Devices Market Growth?
The rise of technological advancements is a significant trend grabbing attention in the stereotactic surgical device market. Key market players are creating innovative technologies to solidify their market standing. For example, in May 2023, Brainlab, a medical technology firm based in Germany, introduced a new product, ExacTrac Dynamic Surface, which is a surface guided radiation therapy (SGRT) patient tracking and positioning system. The system incorporates high-speed thermal surface tracking technology with an updated version of ExacTrac X-ray monitoring, enhancing the flexibility and precision of patient positioning and monitoring for different treatments, including cranial and spine stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). It utilizes a structured blue light pattern projected onto the patient surface, being captured by two 3D cameras, and each surface point comes with a thermal signature, detected by the third in-unit camera.

How Is the Stereotactic Surgery Devices Market Segmented?
The stereotactic surgery devices market covered in this report is segmented -

1) By Product: Gamma Knife, Line Accelerator (LINAC) Machines, Proton Beam, CyberKnife
2) By Application: Brain Tumor Treatment, Arteriovenous Malformations Treatment, Parkinsons Disease, Epilepsy, Other Applications
3) By End User: Hospitals, Laboratories

Subsegments:
1) By Gamma Knife: Leksell Gamma Knife Perfexion, Leksell Gamma Knife Icon
2) By Line Accelerator (LINAC) Machines: Conventional LINAC, Image-Guided Radiation Therapy (IGRT) LINAC
3) By Proton Beam: Fixed Beam Proton Therapy Systems, Scanned Beam Proton Therapy Systems
4) By CyberKnife: CyberKnife M6 System, CyberKnife VSI System

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10495&type=smp

Which Companies Are Leading the Charge in Stereotactic Surgery Devices Market Innovation?
Major companies operating in the stereotactic surgery devices market include Alliance Oncology, Micromar Industria Commercio Ltda., Adeor Medical AG, Monteris Medical Holding AG, Inomed Medizintechnik GmbH, Ion Beam Applications S.A. (IBA), Elekta AB (publ), Varian Medical Systems Inc., Accuracy Incorporated, Modus Medical Devices Inc., Koninklijke Philips N.V., Huiheng Group Co. Ltd., Mitsubishi Heavy Industries Ltd., GE Healthcare, Siemens AG, Medtronic plc, Brainlab AG, Renishaw plc, Neuropace Inc., Microvention Inc., MR Solutions Ltd., RaySearch Laboratories AB, Alpha Omega Engineering Inc., FHC Inc., Nexstim Plc, Scopis GmbH, IZI Medical Products LLC, Integra LifeSciences Holdings Corporation, Computerized Imaging Reference Systems Inc., MRI Interventions Inc., ZAP Surgical Systems Inc., Schaerer Medical USA Inc.

Which Regions Are Leading the Global Stereotactic Surgery Devices Market in Revenue?
North America was the largest region in the stereotactic surgery devices market in 2024. The regions covered in the stereotactic surgery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10495

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.